2.3. Analysis.
Comparison 2 COMPARISON 2. ARIPIPRAZOLE versus QUETIAPINE, Outcome 3 Global state: 2b. Average endpoint scale score (medium term, 12 to 24 weeks, high=poor).
Comparison 2 COMPARISON 2. ARIPIPRAZOLE versus QUETIAPINE, Outcome 3 Global state: 2b. Average endpoint scale score (medium term, 12 to 24 weeks, high=poor).